MedPath

ONCASPAR

ONCASPAR

Approved
DIN Number

02461900

Drug Class

Human

Market Date

Jun 1, 2017

Company
HC

servier canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02461900
AIG Number0131872001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01XX24 PEGASPARGASE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PEGASPARGASEActive
Strength: 750 UNIT / ML
Monograph: PEGASPARGASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.